期刊文献+

Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H pylori infection 被引量:1

Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H pylori infection
下载PDF
导出
摘要 AIM: To determine, by counting sister chromatid exchange (SCE) frequencies, whether genetic impairment and DNA damage have an effect on the pathogenesis of gastric cancer (GC). METHODS: Analysis of SCE is a cytogenetic technique used to show DNA damage as a result of an exchange of DNA fragments between sister chromatids. We analyzed SCE frequency in 24 patients with GC, 26 patients with chronic atrophic gastritis (CAG), and 15 normal controls. The presence of H pylori was confirmed by urease test, toluidine-blue stain and hematoxylin-eosin stain. RESULTS: SCE was significantly increased in H pylori- negative GC patients, and in H pylori-negative CAG patients compared with controls (7.41 ± 1.36 and 6.92 ± 1.20, respectively, vs 5.54 ± 0.8, P < 0.001). There was no difference in the SCE frequency between H pylori- negative GC patients and H pylori-negative CAG patients (P > 0.05). On other hand, the SCE frequencies in H pylori-positive GC patients were higher than those in H pylori-positive CAG patients (9.20 ± 0.94 vs 7.93 ± 0.81, P < 0.01). Furthermore, H pylori-positive GC patients had a higher SCE frequency than H pylori- negative GC patients (9.20 ± 0.94 vs 7.41 ± 1.36, P < 0.001). Similarly, a significant difference was detected between H pylori-positive CAG patients and H pylori-negative CAG patients (7.93 ± 0.81 vs 6.92 ± 1.20, P < 0.05). CONCLUSION: We suggest the increased SCE in patients reflects a genomic instability that may be operative in gastric carcinogenesis. AIM: To determine, by counting sister chromatid exchange (SCE) frequencies, whether genetic impairment and DNA damage have an effect on the pathogenesis of gastric cancer (GC). METHODS: Analysis of SCE is a cytogenetic technique used to show DNA damage as a result of an exchange of DNA fragments between sister chromatids. We analyzed SCE frequency in 24 patients with GC, 26 patients with chronic atrophic gastritis (CAG), and 15 normal controls. The presence of H pylori was confirmed by urease test, toluidine-blue stain and hematoxylin-eosin stain. RESULTS: SCE was significantly increased in H pylori- negative GC patients, and in H pylori-negative CAG patients compared with controls (7.41 ± 1.36 and 6.92 ± 1.20, respectively, vs 5.54 ± 0.8, P 〈 0.001). There was no difference in the SCE frequency between H pylori- negative GC patients and H pylori-negative CAG patients (P 〉 0.05). On other hand, the SCE frequencies in H pylori-positive GC patients were higher than those in H pylori-positive CAG patients (9.20 ± 0.94 vs 7.93 ± 0.81, P 〈 0.01). Furthermore, H pylori-positive GC patients had a higher SCE frequency than H pylori- negative GC patients (9.20 ± 0.94 vs 7.41 ± 1.36, P 〈 0.001). Similarly, a significant difference was detected between H pylori-positive CAG patients and H pylori-negative CAG patients (7.93 ± 0.81 vs 6.92 ± 1.20, P 〈 0.05). CONCLUSION: We suggest the increased SCE in patients reflects a genomic instability that may be operative in gastric carcinogenesis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第16期2534-2539,共6页 世界胃肠病学杂志(英文版)
关键词 胃癌 慢性萎缩性胃炎 发病机理 幽门感染 Gastric carcinoma Chronic atrophic gastritis Pathogenesis Helicobacter pylori infection Sisterchromatid exchange
  • 相关文献

参考文献12

  • 1Gregory W. Konat.H2O2-induced higher order chromatin degradation: A novel mechanism of oxidative genotoxicity[J].Journal of Biosciences.2003(1)
  • 2S. Loft,H. E. Poulsen.Cancer risk and oxidative DNA damage in man[J].Journal of Molecular Medicine.1996(6)
  • 3Helleday T.Pathways for mitotic homologous recombination in mammalian cells[].Mutation Research.2003
  • 4Liu TZ,Stern A,Emerit I.Clastogenic factors: biomarkers of oxidative stress of potential utility in the clinical chemistry laboratory[].Annals of Clinical and Laboratory Science.1999
  • 5Parkin DM,,Bray F,Ferlay J,Pisani P.Global cancer statistics,2002[].CA A Cancer Journal for Clinicians.2005
  • 6Damjonov I,Linder J.Stomach and Duodenum[].Anderson’s pathology.1996
  • 7Testino G.Gastric preneoplastic changes[].Recenti Progressi in Medicina.2004
  • 8Victor D.Pasechnikov,Sergey Z.Chukov,Sergey M. Kotelevets,Alexander N. Mostovov,Varvara P. Mernova,Maria B. Polyakova.Possibility of non-invasive diagnosis of gastric mucosal precancerous changes[J].World Journal of Gastroenterology,2004,10(21):3146-3150. 被引量:7
  • 9Rosai J.Ackerman‘s surgical pathology[]..1989
  • 10Matozaki T,Sakamoto C,Suzuki T,Matsuda K,Uchida T,Nakano O,Wada K,Nishisaki H,Konda Y,Nagao M.p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells[].Cancer Research.1992

二级参考文献21

  • 1Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2 Concensus Report. Aliment Pharmacol Ther 2002; 16:167-180.
  • 2Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52:6735-6740.
  • 3Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-3560.
  • 4Kiyohira K, Yoshihara M, Iio M, Haruma K, Tanaka S,Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis;evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003; 38:332-338.
  • 5Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O, Alanko A, Harkonen M. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis. An observational case-control study. Scand J Gastroenterol 2002;37:785-791.
  • 6Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349:1269-1276.
  • 7Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2:58-60.
  • 8Kuipers E J, Uyterlinde AM, Pena AS, Roosendaal R, Pals G,Nelis GF. Long term sequelae of Helicobacter pylori gastritis.Lancet 1995; 345:1525-1528.
  • 9Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M.Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35:173-177.
  • 10Kuipers EJ. Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998; 12(Suppl 1): $25-36.

共引文献6

同被引文献5

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部